BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: MacLennan GT, Cheng L. Five decades of urologic pathology: the accelerating expansion of knowledge in renal cell neoplasia. Hum Pathol 2020;95:24-45. [PMID: 31655169 DOI: 10.1016/j.humpath.2019.09.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Mohanty SK, Lobo A, Cheng L. The 2022 revision of World Health Organization classification of tumors of the urinary system and male genital organs: advances and challenges. Hum Pathol 2022:S0046-8177(22)00224-6. [PMID: 36084769 DOI: 10.1016/j.humpath.2022.08.006] [Reference Citation Analysis]
2 Amin MB, McKenney JK, Martignoni G, Campbell SC, Pal S, Tickoo SK. Low grade oncocytic tumors of the kidney: a clinically relevant approach for the workup and accurate diagnosis. Mod Pathol 2022. [PMID: 35896615 DOI: 10.1038/s41379-022-01108-5] [Reference Citation Analysis]
3 Alaghehbandan R, Williamson SR, McKenney JK, Hes O. The Histologic Diversity of Chromophobe Renal Cell Carcinoma With Emphasis on Challenges Encountered in Daily Practice. Adv Anat Pathol 2022;29:194-207. [PMID: 35470289 DOI: 10.1097/PAP.0000000000000349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Whaley RD, Cheng L. Clinicopathologic and Immunohistochemical Characterization of Sarcomatoid Chromophobe Renal Cell Carcinoma: An Analysis of 22 Cases. Am J Surg Pathol 2022. [PMID: 35687360 DOI: 10.1097/PAS.0000000000001926] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Alaghehbandan R, Przybycin CG, Verkarre V, Mehra R. Chromophobe renal cell carcinoma: Novel molecular insights and clinicopathologic updates. Asian Journal of Urology 2021. [DOI: 10.1016/j.ajur.2021.11.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Al-Obaidy KI, Cheng L. Renal oncocytoma with adverse pathologic features: a clinical and pathologic study of 50 cases. Mod Pathol 2021. [PMID: 34103666 DOI: 10.1038/s41379-021-00849-z] [Reference Citation Analysis]
7 Lopez-Beltran A, Cimadamore A, Montironi R, Cheng L. Molecular pathology of urothelial carcinoma. Hum Pathol 2021;113:67-83. [PMID: 33887300 DOI: 10.1016/j.humpath.2021.04.001] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
8 Cimadamore A, Cheng L, Scarpelli M, Massari F, Mollica V, Santoni M, Lopez-Beltran A, Montironi R, Moch H. Towards a new WHO classification of renal cell tumor: what the clinician needs to know-a narrative review. Transl Androl Urol 2021;10:1506-20. [PMID: 33850785 DOI: 10.21037/tau-20-1150] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
9 Zoumpourlis P, Genovese G, Tannir NM, Msaouel P. Systemic Therapies for the Management of Non-Clear Cell Renal Cell Carcinoma: What Works, What Doesn't, and What the Future Holds. Clin Genitourin Cancer 2021;19:103-16. [PMID: 33358151 DOI: 10.1016/j.clgc.2020.11.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
10 Akgul M, Cheng L. Immunophenotypic and pathologic heterogeneity of unclassified renal cell carcinoma: a study of 300 cases. Hum Pathol 2020;102:70-8. [PMID: 32619439 DOI: 10.1016/j.humpath.2020.06.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
11 Cheng J, Han Z, Mehra R, Shao W, Cheng M, Feng Q, Ni D, Huang K, Cheng L, Zhang J. Computational analysis of pathological images enables a better diagnosis of TFE3 Xp11.2 translocation renal cell carcinoma. Nat Commun 2020;11:1778. [PMID: 32286325 DOI: 10.1038/s41467-020-15671-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]